The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis

J Neurooncol. 2016 Sep;129(2):363-71. doi: 10.1007/s11060-016-2185-y. Epub 2016 Jun 20.

Abstract

This study aimed to compare the detectability of brain metastases using contrast-enhanced spin-echo (SE) and gradient-echo (GRE) T1-weighted images. The Ovid-MEDLINE and EMBASE databases were searched for studies on the detectability of brain metastases using contrast-enhanced SE or GRE images. The pooled proportions for the detectability of brain metastases were assessed using random-effects modeling. Heterogeneity among studies was determined using χ (2) statistics for the pooled estimates and the inconsistency index, I (2) . To overcome heterogeneity, subgroup analyses according to slice thickness and lesion size were performed. A total of eight eligible studies, which included a sample size of 252 patients and 1413 brain metastases, were included. The detectability of brain metastases using SE images (89.2 %) was higher than using GRE images (81.6 %; adjusted 84.0 %), but this difference was not statistically significant (p = 0.2385). In subgroup analysis of studies with 1-mm-thick slices and small metastases (<5 mm in diameter), 3-dimensional (3D) SE images demonstrated a higher detectability in comparison to 3D GRE images (93.7 % vs 73.1 % in 1-mm-thick slices; 89.5 % vs 59.4 % for small metastases) (p < 0.0001). Although both SE or GRE images are acceptable for detecting brain metastases, contrast-enhanced 3D SE images using 1-mm-thick slices are preferred for detecting brain metastases, especially small lesions (<5 mm in diameter).

Keywords: Brain metastasis; Detectability; Gradient-echo; Spin-echo.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Brain / diagnostic imaging*
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / secondary
  • Contrast Media / pharmacokinetics*
  • Female
  • Humans
  • Imaging, Three-Dimensional
  • Magnetic Resonance Imaging*
  • Male

Substances

  • Contrast Media